Schedule 13G ownership disclosure

KERYX BIOPHARMACEUTICALS INC

Security class unavailable · CUSIP: 492515101

Event date: 2014-09-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
19.9300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001061768-14-000038
Form type
SC 13G/A
Filer
BAUPOST GROUP LLC/MA
CIK
CIK 1061768
Filed
Oct 09, 2014
Reporting period
Sep 30, 2014
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub